Pharmacetical Newswire

Pharmaceutical News!

Press release distribution service
Pharmaceutical Links

Pharmanewswire.Com: Pharmaceutical News

Facial Rejuvenation Market 2018 : Analysed by Business Growth, Development Factors and Future Prospects by Dominated Players Biopolymer gmbh & co kg (germany), merz gmbh & co. Kgaa (germany), lumenis (u.s.), revance therapeutics, inc. (u.s,), speciality e

 



(PharmaNewsWire.Com, August 07, 2018 ) Global Facial Rejuvenation Market
Facial rejuvenation is a combination of medical and cosmetic procedure that is carried out the youthful appearance to the human face. Facial rejuvenation is carried by either minimally invasive or non-invasive treatment which aims to restore skin elasticity and enables maintain a youthful appearance in the neck and face region. Facial rejuvenation plays a vital role in skin protection from sun damage. In young ages, human naturally defend their bodies from sun damage by neutralization of free radicals which are reactive oxygen atoms damage the skin’s collagen. However, human bodies lose the resistance towards ultra violet radiations in older age. The signs of sun damage include wrinkles, enlarged pores, sagging skin, freckling or spotting and spider veins. Many treatments such as microabrasion, dermabrasion, topical creams, chemical peels, dermal fillers, and cosmetic surgery are available for the protection of skin from sun damage.

Get Free Sample Report@ https://www.qurateresearch.com/report/sample/HnM/QBI-PBI-HnM-3236

The global Facial Rejuvenation Market is expected to grow at a significant CAGR due to increase in the global population. Rise in the disposable income levels, lifestyle changes, early onset of aging, and increasing adoption of minimally invasive or non-invasive surgical rejuvenation procedures expected fuel the facial rejuvenation market. Furthermore, simple procedures for the treatments, rise in the affordability, availability of beauty products in the market, and shorter treatment duration by patients also boost the facial rejuvenation market over the forecast period. However, lack of properly trained professionals, limited documented evidence of clinical effectiveness, and the implementation of international regulatory mandates for the standardization of cosmetic procedures are the major bottle necks for the growth of facial rejuvenation market over the forecast period.
Facial rejuvenation market is segmented based on the product type, and end-user

Based on product type, the facial rejuvenation market is segmented into the following:
Topical Rejuvenation Products
Keratolytics
Moisturizers
Retinoids
Sunscreens
Hair Removals
Botulinum Products
Dermal Fillers
Absorbable
Non absorbable
Chemical peels
Micro abrasion equipment
Equipment
Laser based equipment
Ultrasound-based equipment

Based on the end-user, facial rejuvenation market is segmented into the following:
Hospitals
Dermatology clinics
Others

Market players are adopting various key strategies that include acquisitions and mergers, collaborations, agreements, product approvals, and launching of new products to increase share in the facial rejuvenation market. For instance, in June 2009, Anika Therapeutics, signed an exclusive U.S. distribution agreement with Palo Alto, Coapt Systems, Inc. for its aesthetic dermatology franchise. Coapt Systems’ suite of bioabsorbable implants for use in facial aesthetic and rejuvenation procedures is highly complementary to Anika’s injectable filler that corrects lines and wrinkles on the face. In addition, in July 2008, Johnson & Johnson received U.S. Food and Drug Administration clearance to market Evolence, an injectable collagen for treating facial wrinkles. Moreover, in April 2017, Merz Pharma made a strategic venture investment in Cytrellis Biosystems, for developing a new class of non-surgical products to combat sagging skin associated with aging.

Enquiry for Customization@ https://www.qurateresearch.com/report/customize/HnM/QBI-PBI-HnM-3236

Geographically, the facial rejuvenation market has been segmented into following regions Viz. North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa. North America dominates the facial rejuvenation market. Owing to change in the lifestyle, increase in the healthcare expenditure and skilled professionals the region for minimally invasive surgeries. Europe facial rejuvenation market holds a dominant share attributed to increase in the aging population, technological developments in the facial rejuvenation procedures such as minimally invasive or non-surgical procedures might fuel the market in European region over the forecast period. Asia-Pacific accounts for the significant share due to increase in the population companies setting up manufacturing facilities in the region. In addition, rising awareness about skin problems is also supporting the growth of facial rejuvenation market in Asia-Pacific region over the forecast period.

Some of the players in facial rejuvenation market are Biopolymer GmbH & Co KG (Germany), Merz GmbH & Co. KGaA (Germany), Lumenis (U.S.), Revance Therapeutics, Inc. (U.S,), Speciality European Pharma (U.K.), Mentor Worldwide LLC (U.K.), Anika Therapeutics, Inc. (U.S.), Contura International A/S (Denmark), Cynosure, Inc. (U.S.), Fibrocell Science Inc. (U.S,), and Galderma S/A (Switzerland) to name a few.



Qurate Business Intelligence

Nehal Chinoy

+919881074592

nehal@qurateresearch.com

Source: EmailWire.Com

Source: EmailWire.com


Pharmaceutical Sponsors

Free Biotech & Pharmaceutical Magazines

Pharmacy Newswire Video Feed

Pharmaceutical & Biotech Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:

IronPort Provides Email Management and Analysis for a Premier Health Care Solutions Provider
Pharmaceutical & Medical Packaging News
Medical Laboratory Observer

No credit cards, coupons, or promo codes required. Try it today!

Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com, or contact us.
Copyright 2009 GroupWeb Media LLC
GroupWeb Media Network

Aviation-NewsWire | ArtNewsWire | Auction NewsWire | CRM NewsWire | ePhotoNewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | i-Homeland Security.Com | iMac-NewsWire.Com | i-Press-Release-Service | i-SoftwareNews.com | iT-NewsWire.Com
| i-TravelNewsWire.Com | MoneyNewsWire.Net | Movie-Stars-News.Com | MSNewsWire.Net | PharmaNewsWire.Com | Publishing-NewsWire.Com | RSSNewsWire.Net | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com | VoIPNewsWire.Net | XSportsWorld.Net
Pharmanewswire.com - Pharmaceutical Newswire and Press Release service of GroupWeb Media LLC